278 related articles for article (PubMed ID: 18805456)
1. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
[TBL] [Abstract][Full Text] [Related]
2. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
[TBL] [Abstract][Full Text] [Related]
3. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
[TBL] [Abstract][Full Text] [Related]
4. The development of standardized case definitions and guidelines for adverse events following immunization.
Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
[No Abstract] [Full Text] [Related]
5. The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI).
Bonhoeffer J; Kohl K; Chen R; Duclos P; Heijbel H; Heininger U; Jefferson T; Loupi E
Vaccine; 2002 Dec; 21(3-4):298-302. PubMed ID: 12450705
[TBL] [Abstract][Full Text] [Related]
6. Applicability of the Brighton Collaboration Case Definition for seizure after immunization in active and passive surveillance in Canada.
Top KA; Constantinescu CM; Laflèche J; Bettinger JA; Scheifele DW; Vaudry W; Halperin SA; Law BJ
Vaccine; 2013 Nov; 31(48):5700-5. PubMed ID: 24099871
[TBL] [Abstract][Full Text] [Related]
7. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
Schumacher Z; Bourquin C; Heininger U
Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
[TBL] [Abstract][Full Text] [Related]
9. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
10. The monitoring of adverse events following immunization.
Tatley M
N Z Med J; 2002 Nov; 115(1165):U247; author reply U247. PubMed ID: 12552289
[No Abstract] [Full Text] [Related]
11. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
12. Safety reporting in developing country vaccine clinical trials-a systematic review.
Muehlhans S; Richard G; Ali M; Codarini G; Elemuwa C; Khamesipour A; Maurer W; Mworozi E; Kochhar S; Rundblad G; Vuitton D; Rath B
Vaccine; 2012 May; 30(22):3255-65. PubMed ID: 22406279
[TBL] [Abstract][Full Text] [Related]
13. Suggestions for improving the monitoring of adverse events following immunization in New Zealand.
Miller M; Turner N
N Z Med J; 2002 Sep; 115(1162):U186. PubMed ID: 12386665
[No Abstract] [Full Text] [Related]
14. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
[TBL] [Abstract][Full Text] [Related]
15. A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting System.
McNeil MM; Ma G; Aranas A; Payne DC; Rose CE
Vaccine; 2007 Apr; 25(17):3428-36. PubMed ID: 17258846
[TBL] [Abstract][Full Text] [Related]
16. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
Chang S; Ball R; Braun MM
Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria.
Clothier HJ; Crawford NW; Kempe A; Buttery JP
Commun Dis Intell Q Rep; 2011 Dec; 35(4):294-8. PubMed ID: 22624490
[TBL] [Abstract][Full Text] [Related]
18. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System.
Woo EJ; Burwen DR; Gatumu SN; Ball R;
Clin Infect Dis; 2003 Aug; 37(3):351-8. PubMed ID: 12884159
[TBL] [Abstract][Full Text] [Related]
19. Reporting of adverse events following immunization in Australia.
Isaacs D; Lawrence G; Boyd I; Ronaldson K; McEwen J
J Paediatr Child Health; 2005 Apr; 41(4):163-6. PubMed ID: 15813867
[TBL] [Abstract][Full Text] [Related]
20. Developing a national system for dealing with adverse events following immunization.
Mehta U; Milstien JB; Duclos P; Folb PI
Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
